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We appreciate Dr. Kamphuis et al’s and Dr. Ricci et al’s interest in our article.1 We agree 
that male factor infertility incorporates a range of disease severity. Findings from a recent 
study indicate no association between male factor infertility and perinatal outcome.2 The 
rate of intracytoplasmic sperm injection use in our study was not surprising; in 2010, 
intracytoplasmic sperm injection was used in 66% of fresh, nondonor in vitro fertilization 
cycles in the United States, regardless of infertility diagnosis.3 We agree that surveillance 
data are limited by the lack of some historical medical information, and this was noted as a 
limitation in the article. The aim of this observational study was not to suggest causality but 
to evaluate a potential association. Although we were unable to separate iatrogenic from 
spontaneous preterm birth, we did stratify by early-preterm and late-preterm birth because 
most iatrogenic preterm birth occurs at later gestational ages. After stratification, the 
association between tubal factor infertility and preterm birth remained. Although propensity 
scores could have been used to account for possible confounding by obstetric history and 
maternal age, its use would have reduced the sample size, depending on the closeness of the 
matching algorithm. We considered regression analysis to be preferable because it is an 
established and accepted tool for evaluation of confounding and allowed us to capitalize on 
the large study population.
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We maintain that the decrease in the percentage of total assisted reproductive technology 
cycles holding a tubal factor diagnosis reflects increased alternative indications such as 
diminished ovarian reserve. Although Chlamydia trachomatis rates have increased, hospital 
admissions for pelvic inflammatory disease have decreased.4 Pelvic inflammatory disease, 
rather than chlamydial infection, may explain more accurately the decrease in absolute 
number of tubal factor cycles. Regarding the potential effect of selective reduction, our 
analysis demonstrated an association between poor perinatal outcome and tubal disease 
among singleton pregnancies after controlling for number of fetal heartbeats at first 
ultrasound scan.
Our study should be interpreted with care and is subject to several limitations. Future studies 
that include additional preterm birth risk factors may help to delineate the association 
between tubal disease and preterm birth.
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